TCM
Tygh Capital Management Portfolio holdings
AUM
$782M
This Quarter Return
+4.28%
1 Year Return
+39.44%
3 Year Return
+251.65%
5 Year Return
+418.54%
10 Year Return
–
AUM
$739M
AUM Growth
+$4.94M
(+0.67%)
Cap. Flow
+$1.79M
Cap. Flow
% of AUM
0.24%
Top 10 Holdings %
Top 10 Hldgs %
22.99%
Holding
106
New
18
Increased
48
Reduced
21
Closed
19
Top Buys
| 1 |
Clean Harbors
CLH
|
$13.7M |
| 2 |
Casella Waste Systems
CWST
|
$12.3M |
| 3 |
BlackLine
BL
|
$12M |
| 4 |
FOCS
Focus Financial Partners Inc. Class A
FOCS
|
$11.9M |
| 5 |
Aspen Aerogels
ASPN
|
$9.49M |
Top Sells
| 1 |
Kirby Corp
KEX
|
$9.27M |
| 2 |
Element Solutions
ESI
|
$8.66M |
| 3 |
Bio-Rad Laboratories Class A
BIO
|
$7.78M |
| 4 |
PACW
PacWest Bancorp
PACW
|
$7.48M |
| 5 |
MSC Industrial Direct
MSM
|
$7.4M |
Sector Composition
| 1 | Technology | 31.59% |
| 2 | Healthcare | 21.24% |
| 3 | Industrials | 20.95% |
| 4 | Consumer Discretionary | 13.29% |
| 5 | Financials | 6.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Cardlytics
CDLX
$47.4M
| $3.48M | 0.47% |
41,432
-19,931
| -32% | -$1.67M |
|
77
Halozyme
HALO
$8.75B
| $3.43M | 0.46% |
84,244
+9,419
| +13% | +$383K |
|
78
Alkermes
ALKS
$4.95B
| $3.03M | 0.41% |
+98,265
| New | +$3.03M |
|
79
Twist Bioscience
TWST
$1.57B
| $2.99M | 0.4% |
+27,967
| New | +$2.99M |
|
80
Fate Therapeutics
FATE
$115M
| $2.89M | 0.39% |
48,773
+12,358
| +34% | +$733K |
|
81
Denali Therapeutics
DNLI
$2.24B
| $2.74M | 0.37% |
+54,335
| New | +$2.74M |
|
82
TG Therapeutics
TGTX
$5.03B
| $2.61M | 0.35% |
+78,268
| New | +$2.61M |
|
83
BridgeBio Pharma
BBIO
$9.91B
| $2.01M | 0.27% |
+42,934
| New | +$2.01M |
|
84
Beam Therapeutics
BEAM
$1.9B
| $2M | 0.27% |
+22,943
| New | +$2M |
|
85
CareDx
CDNA
$678M
| $1.95M | 0.26% |
+30,720
| New | +$1.95M |
|
86
PTC Therapeutics
PTCT
$4.41B
| $1.73M | 0.23% |
46,472
+8,189
| +21% | +$305K |
|
87
Apellis Pharmaceuticals
APLS
$3.51B
| $1.24M | 0.17% |
+37,617
| New | +$1.24M |
|
88
Arcosa
ACA
$4.74B
| – | – |
-86,644
| Closed | -$5.09M |
|
89
Addus HomeCare
ADUS
$2.08B
| – | – |
-15,000
| Closed | -$1.31M |
|
90
Alamo Group
ALG
$2.53B
| – | – |
-21,900
| Closed | -$3.34M |
|
91
Avanos Medical
AVNS
$573M
| – | – |
-18,000
| Closed | -$655K |
|
|
92
Bio-Rad Laboratories Class A
BIO
$7.8B
| – | – |
-12,075
| Closed | -$7.78M |
|
93
FibroGen
FGEN
$48.4M
| – | – |
-1,970
| Closed | -$1.31M |
|
94
Five Below
FIVE
$8.33B
| – | – |
-31,451
| Closed | -$6.08M |
|
95
Fox Factory Holding Corp
FOXF
$1.16B
| – | – |
-37,296
| Closed | -$5.81M |
|
|
96
Kirby Corp
KEX
$4.95B
| – | – |
-152,865
| Closed | -$9.27M |
|
97
Monarch Casino & Resort
MCRI
$1.87B
| – | – |
-89,462
| Closed | -$5.92M |
|
|
98
MSC Industrial Direct
MSM
$5.03B
| – | – |
-82,468
| Closed | -$7.4M |
|
99
Nexstar Media Group
NXST
$6.24B
| – | – |
-30,163
| Closed | -$4.46M |
|
100
Primoris Services
PRIM
$6.22B
| – | – |
-171,572
| Closed | -$5.05M |
|